Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

NCT04205968 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

94

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Small Intestinal Adenocarcinoma
Stage III Small Intestinal Adenocarcinoma AJCC v8
Stage IIIA Small Intestinal Adenocarcinoma AJCC v8
Stage IIIB Small Intestinal Adenocarcinoma AJCC v8
Stage IV Small Intestinal Adenocarcinoma AJCC v8

Interventions

DRUG: Fluorouracil
DRUG: Irinotecan
DRUG: Irinotecan Hydrochloride
DRUG: Leucovorin
DRUG: Leucovorin Calcium
DRUG: Paclitaxel
BIOLOGICAL: Ramucirumab

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]